Search research articles
Contact Us
Filters
Showing results (71-80 of 189) with videos related to
Page
of 19
Sort By:
The Lancet. Rheumatology
|
October 5, 2020
Defining the scourge of COVID-19 hyperinflammatory syndrome
Randy Q Cron, Grant S Schulert, Rachel S Tattersall
Faculty Reviews
|
March 15, 2021
Recent progress in the treatment of non-systemic juvenile idiopathic arthritis
John M Bridges, Elizabeth D Mellins, Randy Q Cron
Current Opinion in Pediatrics
|
September 17, 2021
Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children
Grant S Schulert, Sydney A Blum, Randy Q Cron
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2005
Pediatric rheumatology for the adult rheumatologist I: therapy and dosing for pediatric rheumatic disorders
Esi M DeWitt, David D Sherry, Randy Q Cron
Frontiers in Immunology
|
May 20, 2026
Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy
William J Freeman, Eileen C Rife, Randy Q Cron
The Journal of Rheumatology
|
March 9, 2007
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis
Edward M Behrens, Timothy Beukelman, Michele Paessler, et al.
The Journal of Rheumatology
|
December 3, 2013
Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors
Ashley Shafferman, Kevin R Fontaine, Randy Q Cron, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
July 29, 2016
Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis
Melissa L Mannion, Linda McAllister, Randy Q Cron, et al.
Frontiers in Immunology
|
February 19, 2019
The Immunology of Macrophage Activation Syndrome
Courtney B Crayne, Sabrin Albeituni, Kim E Nichols, et al.
The Journal of Rheumatology
|
February 9, 2008
Neither cell-surface nor soluble CD154 levels are associated with coronary artery disease in systemic lupus erythematosus
Joan M von Feldt, Sherif Latif, Anna Genin, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 189) with videos related to
Sort By:
Page
of 19
The Lancet. Rheumatology
|
October 5, 2020
Defining the scourge of COVID-19 hyperinflammatory syndrome
Randy Q Cron, Grant S Schulert, Rachel S Tattersall
Faculty Reviews
|
March 15, 2021
Recent progress in the treatment of non-systemic juvenile idiopathic arthritis
John M Bridges, Elizabeth D Mellins, Randy Q Cron
Current Opinion in Pediatrics
|
September 17, 2021
Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children
Grant S Schulert, Sydney A Blum, Randy Q Cron
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 17, 2005
Pediatric rheumatology for the adult rheumatologist I: therapy and dosing for pediatric rheumatic disorders
Esi M DeWitt, David D Sherry, Randy Q Cron
Frontiers in Immunology
|
May 20, 2026
Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy
William J Freeman, Eileen C Rife, Randy Q Cron
The Journal of Rheumatology
|
March 9, 2007
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis
Edward M Behrens, Timothy Beukelman, Michele Paessler, et al.
The Journal of Rheumatology
|
December 3, 2013
Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors
Ashley Shafferman, Kevin R Fontaine, Randy Q Cron, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
July 29, 2016
Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis
Melissa L Mannion, Linda McAllister, Randy Q Cron, et al.
Frontiers in Immunology
|
February 19, 2019
The Immunology of Macrophage Activation Syndrome
Courtney B Crayne, Sabrin Albeituni, Kim E Nichols, et al.
The Journal of Rheumatology
|
February 9, 2008
Neither cell-surface nor soluble CD154 levels are associated with coronary artery disease in systemic lupus erythematosus
Joan M von Feldt, Sherif Latif, Anna Genin, et al.
Page
of 19